Main Session
Sep 27
SS 02 - Escalate, De-escalate, or Substitute? Trials Shaping Prostate Cancer Care

108 - Three-Year Outcomes of a Prospective Randomized Trial of Moderately-Hypofractionated and Standard-Fractionated Proton Therapy in Prostate Cancer Embedded within COMPPARE Trial

03:30pm - 03:40pm ET

Presenter(s)

Nancy Mendenhall, MD, FASTRO Headshot
Nancy Mendenhall, MD, FASTRO - University of Florida Proton Therapy Institute, Jacksonville, FL